Solaris Vaccines, Inc. was formed 2021 to address many of the challenges of creating vaccines in response to emerging threats to global human health.
Current methods of developing and manufacturing vaccines are slow, not fully protective, technically complex, use toxic chemicals, and often have onerous storage requirements.
The Solaris SolaVAX™ method uses riboflavin (vitamin B2) and UV light to rapidly and effectively inactivate pathogens, resulting in a new approach for creating vaccines against pathogens such as viruses, bacteria and parasites.
Current methods of developing and manufacturing vaccines are slow, not fully protective, technically complex, use toxic chemicals, and often have onerous storage requirements.
The Solaris SolaVAX™ method uses riboflavin (vitamin B2) and UV light to rapidly and effectively inactivate pathogens, resulting in a new approach for creating vaccines against pathogens such as viruses, bacteria and parasites.
Investors 1
| Date | Name | Website |
| - | VIC Techno... | victech.co... |
Mentions in press and media 4
| Date | Title | Description |
| 21.06.2023 | Solaris Vaccines Awarded Funding from NIH to Develop Novel Influenza Vaccine using SolaVAX™ Platform | SolaVAX uses UV light and Vitamin B2 to inactivate viruses while preserving their immune-stimulating components “We identified influenza as a top priority given the need for improved vaccines,” stated Dr. Michael Artinger, CEO of Solaris. “... |
| 18.04.2023 | Solaris Vaccines Adds Izabela Ragan as Director of Research and Development for the SolaVAX™ Platform | According to Dr. Ragan, “Joining Solaris Vaccines is a natural next step in my career as I have seen firsthand the advantages of the SolaVAX platform in my previous work. I am eager to continue advancing this technology which has the potent... |
| 14.09.2021 | Solaris Vaccines Formed to Develop and Commercialize a Rapid, Flexible Vaccine Manufacturing Platform | “VIC is thrilled to create a new company focused solely on this exciting approach for generating novel vaccines for known and unknown infectious diseases,” said Michael Artinger, VIC executive vice president, managing director and interim C... |
| - | Solaris Vaccines | “solarisvax.com – Rapid, Safe and Effective Vaccines for Global Health ” |